• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在两年的随访中,作为一种新的预后标志物,卡特西坦在射血分数降低的稳定心力衰竭患者中的作用。

Catestatin as a New Prognostic Marker in Stable Patients with Heart Failure with Reduced Ejection Fraction in Two-Year Follow-Up.

机构信息

Department of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland.

出版信息

Dis Markers. 2020 Oct 1;2020:8847211. doi: 10.1155/2020/8847211. eCollection 2020.

DOI:10.1155/2020/8847211
PMID:33082887
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7556099/
Abstract

. The main goal of the study was to assess the usefulness of plasma concentrations of catestatin as a predictor of a composite endpoint (CE): unplanned hospitalization and death for all causes in patients with HFrEF in the midterm follow-up. . The study group consisted of 52 Caucasian patients in NYHA classes II and III. The control group consisted of 24 healthy volunteers. The biomarkers, whose concentration was assessed before and after physical exertion as well as the variability of their concentration under the influence of the physical exertion, were NT-proBNP, troponin T, and catestatin. . During the 24-month follow-up period, 11 endpoints were recorded. The univariate analysis of the Cox proportional hazard model showed a statistically significant effect of all assessed CST concentrations on the occurrence of CE. In the 24-month follow-up, where the starting concentration of catestatin was compared with other recognized prognostic factors in HF, the initial concentration of catestatin showed statistical significance in CE prognosis as the only parameter tested. . Plasma concentration of catestatin before and after physical exertion is a valuable prognostic parameter in predicting death from all causes and unplanned hospitalization in the group of patients with HFrEF in the 2-year follow-up.

摘要

. 本研究的主要目的是评估血浆茶抑素浓度作为复合终点(CE)的预测因子的有用性:在中期随访中,HFpEF 患者的非计划性住院和全因死亡。. 研究组包括 52 名 NYHA Ⅱ和Ⅲ级的白种人患者。对照组包括 24 名健康志愿者。评估了生物标志物的浓度,这些生物标志物的浓度在体力活动前后以及在体力活动的影响下其浓度的可变性进行了评估,这些生物标志物是 NT-proBNP、肌钙蛋白 T 和茶抑素。. 在 24 个月的随访期间,记录了 11 个终点。Cox 比例风险模型的单变量分析显示,所有评估 CST 浓度对 CE 发生的影响均具有统计学意义。在 24 个月的随访中,将茶抑素的起始浓度与 HF 中其他公认的预后因素进行比较,在 CE 预后中,茶抑素的起始浓度显示出统计学意义,是唯一经过测试的参数。. 运动前后的血浆茶抑素浓度是预测 HFpEF 患者 2 年随访中全因死亡和非计划性住院的有价值的预后参数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ee/7556099/54e7a341ad3b/DM2020-8847211.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ee/7556099/d14a89e4cc15/DM2020-8847211.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ee/7556099/07c501bb0993/DM2020-8847211.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ee/7556099/54e7a341ad3b/DM2020-8847211.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ee/7556099/d14a89e4cc15/DM2020-8847211.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ee/7556099/07c501bb0993/DM2020-8847211.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ee/7556099/54e7a341ad3b/DM2020-8847211.003.jpg

相似文献

1
Catestatin as a New Prognostic Marker in Stable Patients with Heart Failure with Reduced Ejection Fraction in Two-Year Follow-Up.在两年的随访中,作为一种新的预后标志物,卡特西坦在射血分数降低的稳定心力衰竭患者中的作用。
Dis Markers. 2020 Oct 1;2020:8847211. doi: 10.1155/2020/8847211. eCollection 2020.
2
Prognostic Value of Plasma Catestatin Concentration in Patients with Heart Failure with Reduced Ejection Fraction in Two-Year Follow-Up.血浆抑胃肽浓度在射血分数降低的心力衰竭患者两年随访中的预后价值
J Clin Med. 2023 Jun 22;12(13):4208. doi: 10.3390/jcm12134208.
3
Plasma levels and diagnostic value of catestatin in patients with heart failure.心力衰竭患者中 catestatin 的血浆水平及其诊断价值。
Peptides. 2013 Aug;46:20-5. doi: 10.1016/j.peptides.2013.05.003. Epub 2013 May 20.
4
Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.生长分化因子 15 在射血分数保留型与降低型心力衰竭中的作用。
Eur J Heart Fail. 2016 Jan;18(1):81-8. doi: 10.1002/ejhf.431. Epub 2015 Oct 25.
5
[Prognostic value of circulating catestatin levels for in-hospital heart failure in patients with acute myocardial infarction].[循环嗜铬粒蛋白A水平对急性心肌梗死患者院内心力衰竭的预后价值]
Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Nov;40(11):914-9.
6
The predictive value of plasma catestatin for all-cause and cardiac deaths in chronic heart failure patients.血浆抑癌素对慢性心力衰竭患者全因死亡和心脏死亡的预测价值。
Peptides. 2016 Dec;86:112-117. doi: 10.1016/j.peptides.2016.10.007. Epub 2016 Oct 19.
7
Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.用于心力衰竭特征描述的生物标志物——射血分数保留型与射血分数降低型心力衰竭的鉴别
Int J Cardiol. 2017 Jan 15;227:272-277. doi: 10.1016/j.ijcard.2016.11.110. Epub 2016 Nov 9.
8
Prognostic Utility of Troponin I and N Terminal-ProBNP among Patients with Heart Failure due to Non-Ischemic Cardiomyopathy and Important Correlations.肌钙蛋白I和N末端脑钠肽前体在非缺血性心肌病所致心力衰竭患者中的预后价值及重要相关性
Cardiovasc Hematol Agents Med Chem. 2019;17(2):94-103. doi: 10.2174/1871525717666190717160615.
9
Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction.入院时可溶性ST2和N末端脑钠肽前体在射血分数保留、中等范围和降低的心力衰竭中的预后价值。
Acta Cardiol. 2018 Feb;73(1):41-48. doi: 10.1080/00015385.2017.1325617. Epub 2017 Sep 25.
10
Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction.射血分数保留与降低的心衰患者的预后和 NT-proBNP。
Heart. 2019 Aug;105(15):1182-1189. doi: 10.1136/heartjnl-2018-314173. Epub 2019 Apr 8.

引用本文的文献

1
New Cardiovascular Risk Biomarkers in Rheumatoid Arthritis: Implications and Clinical Utility-A Narrative Review.类风湿关节炎中新的心血管风险生物标志物:意义与临床应用——一篇叙述性综述
Biomedicines. 2025 Apr 3;13(4):870. doi: 10.3390/biomedicines13040870.
2
Prognostic value of plasma secretoneurin concentration in patients with heart failure with reduced ejection fraction in one-year follow-up.在一年的随访中,心力衰竭射血分数降低患者血浆分泌素浓度的预后价值。
Ann Med. 2024 Dec;56(1):2305309. doi: 10.1080/07853890.2024.2305309. Epub 2024 Jan 23.
3
Prognostic Value of Plasma Catestatin Concentration in Patients with Heart Failure with Reduced Ejection Fraction in Two-Year Follow-Up.

本文引用的文献

1
Cellular and Molecular Differences between HFpEF and HFrEF: A Step Ahead in an Improved Pathological Understanding.HFpEF 和 HFrEF 之间的细胞和分子差异:在改善病理认识方面迈出的一步。
Cells. 2020 Jan 18;9(1):242. doi: 10.3390/cells9010242.
2
Procalcitonin (PCT) Predicts Worse Outcome in Patients with Chronic Heart Failure with Reduced Ejection Fraction (HFrEF).降钙素原(PCT)可预测射血分数降低的慢性心力衰竭(HFrEF)患者的预后更差。
Dis Markers. 2018 Aug 28;2018:9542784. doi: 10.1155/2018/9542784. eCollection 2018.
3
The predictive value of plasma catestatin for all-cause and cardiac deaths in chronic heart failure patients.
血浆抑胃肽浓度在射血分数降低的心力衰竭患者两年随访中的预后价值
J Clin Med. 2023 Jun 22;12(13):4208. doi: 10.3390/jcm12134208.
4
Role of Catestatin in the Cardiovascular System and Metabolic Disorders.抑肽素在心血管系统及代谢紊乱中的作用。
Front Cardiovasc Med. 2022 May 19;9:909480. doi: 10.3389/fcvm.2022.909480. eCollection 2022.
5
Prognostic differences of catestatin among young and elderly patients with acute myocardial infarction.卡替他汀在年轻和老年急性心肌梗死患者中的预后差异。
World J Emerg Med. 2022;13(3):169-174. doi: 10.5847/wjem.j.1920-8642.2022.055.
6
Catestatin as a Biomarker of Cardiovascular Diseases: A Clinical Perspective.癌抑素作为心血管疾病的生物标志物:临床视角
Biomedicines. 2021 Nov 25;9(12):1757. doi: 10.3390/biomedicines9121757.
7
Putative regulation of macrophage-mediated inflammation by catestatin.推测 catestatin 通过调节巨噬细胞介导的炎症反应。
Trends Immunol. 2022 Jan;43(1):41-50. doi: 10.1016/j.it.2021.11.002. Epub 2021 Nov 27.
8
Plasma Catestatin Levels and Advanced Glycation End Products in Patients on Hemodialysis.血液透析患者的血浆抑癌素水平与晚期糖基化终产物
Biomolecules. 2021 Mar 18;11(3):456. doi: 10.3390/biom11030456.
血浆抑癌素对慢性心力衰竭患者全因死亡和心脏死亡的预测价值。
Peptides. 2016 Dec;86:112-117. doi: 10.1016/j.peptides.2016.10.007. Epub 2016 Oct 19.
4
Melanoma cell adhesion molecule as an emerging biomarker with prognostic significance in systolic heart failure.
Biomark Med. 2016 Jul;10(7):733-42. doi: 10.2217/bmm-2016-0053. Epub 2016 Jun 29.
5
Prognostic significance of red cell distribution width and other red cell parameters in patients with chronic heart failure during two years of follow-up.慢性心力衰竭患者红细胞分布宽度及其他红细胞参数在两年随访期间的预后意义
Kardiol Pol. 2016;74(7):657-64. doi: 10.5603/KP.a2016.0004. Epub 2016 Jan 18.
6
Catestatin could ameliorate proliferating changes of target organs in spontaneously hypertensive rats.加压素酶抑制剂可改善自发性高血压大鼠靶器官的增生变化。
Chin Med J (Engl). 2013;126(11):2157-62.
7
Plasma levels and diagnostic value of catestatin in patients with heart failure.心力衰竭患者中 catestatin 的血浆水平及其诊断价值。
Peptides. 2013 Aug;46:20-5. doi: 10.1016/j.peptides.2013.05.003. Epub 2013 May 20.
8
Catestatin is useful in detecting patients with stage B heart failure.在检测 B 期心力衰竭患者时,卡特西坦很有用。
Biomarkers. 2011 Dec;16(8):691-7. doi: 10.3109/1354750X.2011.629058. Epub 2011 Nov 3.
9
The neuropeptide catestatin promotes vascular smooth muscle cell proliferation through the Ca2+-calcineurin-NFAT signaling pathway.神经肽 catestatin 通过 Ca2+-钙调神经磷酸酶-NFAT 信号通路促进血管平滑肌细胞增殖。
Biochem Biophys Res Commun. 2011 Apr 22;407(4):807-12. doi: 10.1016/j.bbrc.2011.03.104. Epub 2011 Apr 2.
10
Chromogranin/secretogranin proteins in murine heart: myocardial production of chromogranin A fragment catestatin (Chga(364-384)).鼠心中的嗜铬粒蛋白/分泌颗粒蛋白:心肌产生嗜铬粒蛋白 A 片段卡肽(Chga(364-384))。
Cell Tissue Res. 2010 Dec;342(3):353-61. doi: 10.1007/s00441-010-1059-4. Epub 2010 Nov 5.